(Q35109122)

6 August 2017

1 reference

title

Pranlukast: a review of its use in the management of asthma (English)

1 reference

Katherine A Lyseng-Williamson

6 August 2017

0 references

1 reference

object named as

Katherine A Lyseng-Williamson

series ordinal

2

0 references

Lewis J. Smith

1 reference

ORCID Public Data File 2021

author name string

Susan J Keam

series ordinal

1

1 reference

PubMed ID

12699401

6 August 2017

Karen L Goa

series ordinal

3

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

63

1 reference

6 August 2017

10

1 reference

6 August 2017

991-1019

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363100-00005

6 August 2017

0 references

cites work

Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma

1 reference

12 December 2020

Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor

1 reference

12 December 2020

Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist

1 reference

12 December 2020

Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle

1 reference

12 December 2020

The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma

1 reference

12 December 2020

Investigation of the mechanism of alcohol-induced bronchial asthma

1 reference

12 December 2020

Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial

1 reference

12 December 2020

ONO-1078: an antagonist of leukotrienes.

1 reference

12 December 2020

Inhibition by a novel peptide leukotriene receptor antagonist ONO-1078 of airway wall thickening and airway hyperresponsiveness to histamine induced by leukotriene C4 or leukotriene D4 in guinea-pigs

1 reference

12 December 2020

Inhibition of endogenous leukotriene-mediated lung anaphylaxis in guinea pigs by a novel receptor antagonist ONO-1078.

1 reference

12 December 2020

Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction

1 reference

12 December 2020

Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma

1 reference

12 December 2020

Double-blind placebo-controlled study of oxatomide in the treatment of childhood asthma

1 reference

12 December 2020

Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma

1 reference

12 December 2020

Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

1 reference

12 December 2020

Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients

1 reference

12 December 2020

Comparison of patients' compliance with prescribed oral and inhaled asthma medications

1 reference

12 December 2020

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

12 December 2020

Newer asthma therapies

1 reference

12 December 2020

The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock

1 reference

12 December 2020

Evaluation of the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time

1 reference

12 December 2020

Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.

1 reference

12 December 2020

Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway

1 reference

12 December 2020

Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist

1 reference

12 December 2020

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

12 December 2020

The pharmacokinetics of pranlukast in healthy young and elderly subjects.

1 reference

12 December 2020

Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma

1 reference

12 December 2020

Leukotriene receptors

1 reference

12 December 2020

Discovery of leukotrienes and development of antileukotriene agents

1 reference

12 December 2020

Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma

1 reference

12 December 2020

Montelukast: a review of its therapeutic potential in persistent asthma

1 reference

12 December 2020

Liberation of histamine and formation of lysocithin-like substances by cobra venom

1 reference

12 December 2020

The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers

1 reference

12 December 2020

Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma

1 reference

12 December 2020

Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor

1 reference

12 December 2020

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

1 reference

12 December 2020

Decreased exhaled nitric oxide in mild persistent asthma patients treated with a leukotriene receptor antagonist, pranlukast

1 reference

12 December 2020

Azelastine--a novel in vivo inhibitor of leukotriene biosynthesis: a possible mechanism of action: a mini review

1 reference

12 December 2020

Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?

1 reference

12 December 2020

Regulation of leukotrienes in the management of asthma: biology and clinical therapy

1 reference

12 December 2020

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

1 reference

12 December 2020

Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist

1 reference

12 December 2020

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

1 reference

12 December 2020

Characterization of the human cysteinyl leukotriene CysLT1 receptor

1 reference

12 December 2020

A second cysteinyl leukotriene receptor in human lung

1 reference

12 December 2020

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

12 December 2020

Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast

1 reference

12 December 2020

Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma

1 reference

12 December 2020

Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist

1 reference

12 December 2020

Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study

1 reference

12 December 2020

Purification and characterization of pranlukast hydrolase from rat liver microsomes: the hydrolase is identical to carboxylesterase pI 6.2.

1 reference

12 December 2020

A novel leukotriene antagonist, ONO-1078, inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro

1 reference

12 December 2020

Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma

1 reference

12 December 2020

The effectiveness of the long-term treatment with pranlukast in pediatric patients with mild to moderate asthma

1 reference

12 December 2020

Effect of pranlukast on bronchial inflammation in patients with asthma

1 reference

12 December 2020

Use of anti-inflammatory therapy and asthma mortality in Japan

1 reference

12 December 2020

Leukotrienes as mediators of airway obstruction and inflammation in asthma

1 reference

12 December 2020

Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig.

1 reference

12 December 2020

Effects of pranlukast, a cysteinyl leukotriene antagonist, on bronchial responsiveness to methacholine in aspirin-intolerant asthmatics treated with corticosteroids

1 reference

12 December 2020

Measurement of leukotrienes in humans

1 reference

12 December 2020

Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists

1 reference

12 December 2020

Leukotrienes in the pathogenesis of asthma

1 reference

12 December 2020

Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun.

1 reference

12 December 2020

Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal

1 reference

12 December 2020

Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma

1 reference

12 December 2020

What are the alternatives to increasing inhaled corticosteroids for the long term control of asthma?

1 reference

12 December 2020

The discovery of the leukotrienes

1 reference

12 December 2020

Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics

1 reference

12 December 2020

The role of leukotriene modifiers in the treatment of asthma

1 reference

12 December 2020

Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.

1 reference

12 December 2020

Inhibitory effect of a peptide leukotriene antagonist ONO-1078 on LTD4- and antigen-induced thromboxane B2 production in guinea pig lungs

1 reference

12 December 2020

Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis

1 reference

12 December 2020

1 reference

12 December 2020

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

1 reference

12 December 2020

Effect of a peptide leukotriene antagonist, ONO-1078 on antigen-induced airway microvascular leakage in actively sensitized guinea pigs

1 reference

12 December 2020

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

1 reference

12 December 2020

[Effect of a leukotriene antagonist, pranlukast hydrate, on exercise-induced asthma for 14 days]

1 reference

12 December 2020

The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma

1 reference

12 December 2020

Characterization of the human cysteinyl leukotriene 2 receptor

1 reference

12 December 2020

In vivo pharmacologic profile of ONO-1078: a potent, selective and orally active peptide leukotriene (LT) antagonist

1 reference

12 December 2020

Effect of ONO-1078, a leukotriene antagonist, on capsaicin- and substance P-induced bronchoconstriction and airway microvascular leakage in guinea pigs.

1 reference

12 December 2020

Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids

1 reference

12 December 2020

Pharmacokinetic profile of zafirlukast

1 reference

12 December 2020

Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma

1 reference

12 December 2020

Effect of a cysteinyl leukotriene antagonist, pranlukast hydrate, on acetaldehyde-induced bronchoconstriction in asthmatic patients.

1 reference

12 December 2020

The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood

1 reference

12 December 2020

Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics

1 reference

12 December 2020

[Churg-Strauss syndrome during corticosteroid tapering in a patient with bronchial asthma receiving pranlukast]

1 reference

12 December 2020

Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats

1 reference

12 December 2020

Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukast

1 reference

12 December 2020

Compliance with an oral asthma medication: a pilot study using an electronic monitoring device

1 reference

12 December 2020

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

12 December 2020

Early and late asthmatic reaction after allergen challenge

1 reference

12 December 2020

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

1 reference

12 December 2020

Antiinflammatory effects of oxatomide.

1 reference

12 December 2020

Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.

1 reference

12 December 2020

Evaluation before and after pranlukast administration with the QOL questionnaire (revised version 2001) for pediatric patients with bronchial asthma and their parents or caregivers

1 reference

12 December 2020

A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.

1 reference

12 December 2020

Effect of a new leukotriene receptor antagonist, ONO-1078, on human bronchial smooth muscle in vitro

1 reference

12 December 2020

Effects of antileukotrienes in the treatment of asthma

1 reference

12 December 2020

Worldwide clinical experience with the first marketed leukotriene receptor antagonist

1 reference

12 December 2020

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

1 reference

12 December 2020

Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers

1 reference

12 December 2020

Efficacy of antileukotriene agents in asthma management

1 reference

12 December 2020

Challenge studies of a leukotriene receptor antagonist

1 reference

12 December 2020

Pharmacological characterization of leukotriene receptors

1 reference

12 December 2020

Role of cysteinyl leukotrienes in CD4(+) T cell-driven late allergic airway responses

1 reference

12 December 2020

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

1 reference

12 December 2020

The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

1 reference

12 December 2020

Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients

1 reference

12 December 2020

Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.

1 reference

12 December 2020

Leukotriene bronchoconstriction induced by allergen and exercise

1 reference

12 December 2020

Leukotrienes as mediators of asthma.

1 reference

12 December 2020

The effects of a cysteinyl leukotriene antagonist (ONO-1078) on antigen-induced responses in allergic sheep.

1 reference

12 December 2020

Use of leukotriene antagonists in childhood asthma

1 reference

12 December 2020

10.2165/00003495-200363100-00005

Identifiers

DOI

1 reference

PubMed ID

12699401

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12699401